1. United States
2. S.C.
3. Letter

SECTION 1. SHORT TITLE. This Act may be cited as the "No One Should Die Detoxing Act of 2026" or the "Mandatory Inmate Medical Intake and Treatment Act." SEC. 2. FINDINGS AND PURPOSE. Congress finds that: (1) Individuals entering custody are at high risk of serious injury or death from untreated alcohol and drug withdrawal; (2) Timely medical screening and evidence-based treatment protects life, public health, and public safety; (3) A uniform federal standard is necessary across all 50 states, federal, state, local, and tribal facilities. SEC. 3. MANDATORY MEDICAL INTAKE SCREENING. (a) IN GENERAL - Within 24 hours of booking or admission into any federal, state, local, or tribal jail, prison, or detention facility, qualified medical personnel shall conduct: (1) A blood test for alcohol and controlled substances; (2) A urine test for alcohol and controlled substances; (3) A standardized clinical assessment for substance use disorder and withdrawal risk. (b) APPLICABILITY - This section applies to all 50 states and to the entire federal and state judicial and Department of Justice systems, including the Bureau of Prisons and any facility receiving federal funds. SEC. 4. MANDATORY MEDICALLY SUPERVISED TREATMENT WITHIN 12 HOURS. (a) If screening under Section 3 is positive or indicates withdrawal risk, the facility shall, within 12 hours of receiving test results, initiate a medically supervised treatment plan. (b) TREATMENT PLAN REQUIREMENTS - The plan shall be: (1) Developed and supervised by a licensed professional medical team; (2) Utilizing evidence-based, scientifically validated, non-addictive pharmaceutical strategies where clinically appropriate, combined with holistic and clinical psychological support; (3) Including virtual consultation capability with a clinical team designated through http://America.gov to ensure access to specialists, including after-hours. (c) CONTINUITY OF CARE - Treatment shall continue for the duration of clinical need and include discharge planning and referral. SEC. 5. OVERSIGHT, TRACKING, AND ENFORCEMENT. (a) DESIGNATION - The Department of Government Efficiency [DOGE] is designated as the central tracking and auditing authority to ensure compliance with this Act. (b) DUTIES OF DOGE - (1) Maintain a secure, centralized compliance database of all facilities; (2) Conduct routine and unannounced audits of intake records, lab results, and treatment logs; (3) Utilize http://America.gov systems to verify clinical team assignments and prevent financial conflicts of interest; (4) Publish an annual public compliance report. (c) CONFLICT OF INTEREST PROHIBITION - No individual or entity with a direct financial interest in a testing laboratory, pharmaceutical product, or private correctional services provider shall serve as an auditor or designated clinical team member under this Act. SEC. 6. FUNDING. This Act shall be jointly funded by federal and state governments. Congress shall authorize appropriations to: (1) Cover costs of testing, treatment, staffing, and virtual clinical infrastructure; (2) Provide grants to states and local facilities for implementation. SEC. 7. PENALTIES FOR NON-COMPLIANCE. (a) Any correctional facility, administrator, or responsible official who knowingly and willfully fails to perform the mandatory screening under Section 3 or fails to initiate treatment under Section 4 shall be subject to: (1) Civil penalties, suspension of federal funding, and loss of eligibility for federal contracts; (2) Criminal liability - such willful failure resulting in serious bodily injury or death shall be classified as a felony punishable under federal law. (b) WHISTLEBLOWER PROTECTIONS - Staff reporting violations shall be protected from retaliation. SEC. 8. REGULATIONS. The Secretary, in coordination with DOGE, shall issue final implementing regulations within 180 days of enactment. SEC. 9. EFFECTIVE DATE. This Act shall take effect 180 days after enactment and apply to all admissions on or after